1. Home
  2. EVOK vs CHEK Comparison

EVOK vs CHEK Comparison

Compare EVOK & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • CHEK
  • Stock Information
  • Founded
  • EVOK 2007
  • CHEK 2004
  • Country
  • EVOK United States
  • CHEK Israel
  • Employees
  • EVOK N/A
  • CHEK N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • CHEK Medical Electronics
  • Sector
  • EVOK Health Care
  • CHEK Health Care
  • Exchange
  • EVOK Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • EVOK 7.1M
  • CHEK 9.0M
  • IPO Year
  • EVOK 2013
  • CHEK 2015
  • Fundamental
  • Price
  • EVOK $4.81
  • CHEK $0.93
  • Analyst Decision
  • EVOK
  • CHEK
  • Analyst Count
  • EVOK 0
  • CHEK 0
  • Target Price
  • EVOK N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • EVOK 10.0K
  • CHEK 88.2K
  • Earning Date
  • EVOK 03-13-2025
  • CHEK 02-18-2025
  • Dividend Yield
  • EVOK N/A
  • CHEK N/A
  • EPS Growth
  • EVOK N/A
  • CHEK N/A
  • EPS
  • EVOK N/A
  • CHEK N/A
  • Revenue
  • EVOK $8,617,036.00
  • CHEK N/A
  • Revenue This Year
  • EVOK $97.35
  • CHEK N/A
  • Revenue Next Year
  • EVOK $99.52
  • CHEK N/A
  • P/E Ratio
  • EVOK N/A
  • CHEK N/A
  • Revenue Growth
  • EVOK 100.35
  • CHEK N/A
  • 52 Week Low
  • EVOK $3.54
  • CHEK $0.56
  • 52 Week High
  • EVOK $12.32
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 59.77
  • CHEK 42.16
  • Support Level
  • EVOK $4.68
  • CHEK $0.81
  • Resistance Level
  • EVOK $4.94
  • CHEK $1.00
  • Average True Range (ATR)
  • EVOK 0.28
  • CHEK 0.10
  • MACD
  • EVOK 0.06
  • CHEK -0.05
  • Stochastic Oscillator
  • EVOK 73.58
  • CHEK 13.98

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: